Form 4: Omnicell Executive Trades Shares
Statement of Changes in Beneficial Ownership
Omnicell Inc. executive Corey J. Manley reported transactions involving company stock, including share withholding for taxes and a sale under a pre-arranged trading plan.
Summary
- Corey J. Manley, EVP & Chief Legal/Admin Officer at Omnicell, Inc., engaged in stock transactions on May 15, 2026, and May 18, 2026.
- On May 15, 2026, 4,041 shares of common stock were withheld to cover taxes related to the vesting of restricted stock units. The value associated with this transaction was $43.12 per share.
- On May 18, 2026, 5,025 shares of common stock were sold at a price of $43.22 per share.
- The sale on May 18, 2026, was executed under a Rule 10b5-1 trading plan adopted by Mr. Manley on June 13, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it involves stock transactions by an executive, the sale was conducted under a pre-established 10b5-1 plan, and the tax withholding is a routine event.
Positives
- The withholding of shares for tax purposes indicates the vesting of restricted stock units, which is a positive sign of executive compensation and potential stock ownership growth.
- The sale of shares was conducted under a Rule 10b5-1 trading plan, suggesting a pre-determined and structured approach to managing executive stock sales, which can mitigate concerns about insider trading.
Negatives
- The disposal of 5,025 shares of common stock represents a reduction in the executive's direct beneficial ownership of the company's stock.
Risks
- While the sale was part of a 10b5-1 plan, any significant selling by executives can be perceived negatively by the market, potentially impacting share price.
- The tax withholding event, while standard, reduces the number of shares held by the executive.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which solely reports past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by Omnicell's EVP & Chief Legal/Admin Officer is a common practice for executives to diversify their holdings or manage personal financial needs in a compliant manner, especially within the healthcare technology sector where such compensation structures are prevalent.
Stakeholder Impact
- Shareholders: The sale of shares by an executive may be viewed with caution, although the 10b5-1 plan mitigates concerns about opportunistic selling.
- Employees: The vesting of restricted stock units and subsequent tax withholding is a standard part of executive compensation, impacting the executive directly.
- Management: The transactions reflect standard executive financial planning and compliance with SEC regulations.
Next Steps
- Continued monitoring of insider transactions for any significant changes in beneficial ownership that could signal management's confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 06/13/2025 | Date Rule 10b5-1 trading plan was adopted by Corey J. Manley. |
| 05/15/2026 | Date of transaction: withholding of shares for tax coverage. |
| 05/18/2026 | Date of transaction: sale of common stock. |
| 05/19/2026 | Date of filing of the Form 4. |
Keywords
Omnicell, OMCL, Form 4, Insider Trading, Stock Transaction, Executive Compensation, Restricted Stock Units, Rule 10b5-1, Beneficial Ownership, Corey J. Manley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.